Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Mitral surgery on the precipice of transformation

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

William M. DeCampli, MD, PhD

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease Nobuyuki Ishibashi, MD, Richard A. Jonas,

Go on-pump or off-pump in diabetic patients?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

The lord of the rings Antonio Miceli, MD, PhD

The unintended consequences in clinical research

Conduit conundrum: If not two, why three?

Yang Zhang, MD, Haiquan Chen, MD, PhD

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Support Your Specialty

It's not “just a shunt” but sometimes it should be…

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Get it right the first time

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Marc Licker, MD, John Diaper, RA

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Pathologic complete response after esophagectomy following neoadjuvant chemoradiation therapy for esophageal carcinoma: A cure sometimes? Shawn S. Groth,

Taking UP the chronic pulmonary obstructive disease gauntlet

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

How much is enough to warrant prophylactic tricuspid repair?

Prognosis and “granularity”: Building on staging foundations?

Process is helpful, but the procurement problem persists

Jason J. Han, MD, Pavan Atluri, MD

First nights, the adrenal axis, and steroids

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Hope should not spring eternal

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

The continuing challenge of congenital heart disease in China

Bicuspid aortopathy: Seeing the forest for the trees

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

Therapeutic R2 resection for pleural mesothelioma

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Managing conflicts of interest

First in line for robotic surgery: Would you want to know?

Aritoshi Hattori, MD, Kenji Suzuki, MD

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

More than vital: Who bears the burden?

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Who should decide margin length in pulmonary excision of lung cancer?

Did you like Terminator 3 better than Terminator 2

Journal changes and initiatives

Haider J. Warraich, MD, Robert W. Sewell, MD, Robert M. Sade, MD

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Edward Y. Chan, MD, Michael J. Reardon, MD

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Calpain inhibitors: The aspirin of the 21st century?

Presentation transcript:

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found? Robert J. Downey, MD The Journal of Thoracic and Cardiovascular Surgery Volume 155, Issue 3, Pages 1252-1253 (March 2018) DOI: 10.1016/j.jtcvs.2017.10.107 Copyright © 2017 Terms and Conditions

Robert J. Downey, MD The Journal of Thoracic and Cardiovascular Surgery 2018 155, 1252-1253DOI: (10.1016/j.jtcvs.2017.10.107) Copyright © 2017 Terms and Conditions